Cover Image

Would prescription drug importation reduce U.S. drug spending.

Bibliographic Details
Main Author:	Baker, Colin (Colin Sean) (Author)
Format:	Government Document eBook
Language:	English
Published:	[Washington, DC] : Congress of the United States, Congressional Budget Office, [2007]
Series:	Economic and budget issue brief.
Subjects:	Pharmaceutical policy > United States. Prescription pricing > United States. Drugs > Purchasing > United States. Foreign trade regulation > United States.
Online Access:	https://purl.fdlp.gov/GPO/gpo45172

Similar Items

Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005.
Published: (2005)

Drug importation : would the price be right? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the price of drug reimportation, focusing on implications for United States consumers, pricing, research and development, and innovation, February 17, 2005.
Published: (2005)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)

Importation of prescription drugs : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, second session, on examining prescription drug reimportation, focusing on efforts to reduce drug costs, patient safety concerns, recent state action, fraudulent and counterfeit drugs, an international comparison of rising prescription drug expenditures, and S. 2328, to amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, May 20, 2004.
Published: (2005)

Report on prescription drug importation /
Published: (2004)

Effects of using generic drugs on Medicare's prescription drug spending.
by: Somers, Julie
Published: (2010)

Prescription drugs : strategic framework would promote accountability and enhance efforts to enforce the prohibitions on personal importation : report to congressional requesters.
Published: (2005)

Prescription drugs : strategic framework would promote accountability and enhance efforts to enforce the prohibitions on personal importation : report to Congressional requesters.
Published: (2005)

Competition in prescription drug markets, 2017-2022 /
by: Parasrampuria, Sonal, et al.
Published: (2023)

The politics of the international pricing of prescription drugs /
by: Harrison, Christopher Scott
Published: (2004)

The demand for prescription drugs as a function of cost-sharing /
by: Leibowitz, Arleen A.
Published: (1985)

Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)

Prescription drug advertising to consumers : staff report /
Published: (1984)

Would Prescription Drug Importation Reduce U.S. Drug Spending : CBO Economic and Budget Issue Brief /
Published: (2004)

Issues in designing a prescription drug benefit for Medicare.
Published: (2002)

Issues in designing a prescription drug benefit for Medicare.
Published: (2002)

Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Sixth Congress, first session, June 23, 1999.
Published: (1999)

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007.
Published: (2007)

Medicare prescription drug benefit : review and oversight : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, May 8, 2007.
Published: (2007)

Guide to prescription drug costs /
Published: (1980)

Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)

Prescription drug prices : should the federal government regulate them? /
by: Guenther, Gary
Published: (1992)

Public attitudes toward prescription costs and the drug industry : a report /
Published: (1955)

Measuring prescription drug prices : a primer on the CPI Prescription Drug Index /
Published: (2019)

Prescription drugs : modernizing Medicare for the 21st century : hearing before ... 106th Congress, 2nd session, June 14, 2000.
Published: (2000)

Prescription drug price increases : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, first session, July 15, 1985.
Published: (1986)

Prescription drugs : prices available through discount cards and from other sources.
by: Dummit, Laura A.
Published: (2001)

Prescription drug affordability and innovation : addressing challenges in today's market : hearing before the Committee on Finance, United States Senate, One Hundred Fifteenth Congress, second session, June 26, 2018.
Published: (2020)

The cost of prescription drugs : examining the President's blueprint 'American Patients First' to lower drug prices : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining the cost of prescription drugs, focusing on examining the President's blueprint 'American Patients First' to lower drug prices, June 12, 2018.
Published: (2020)

Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)

Reimbursement and access to prescription drugs under Medicare part B : hearing before the Subcommittee on Health Care of the Committee on Finance, United States Senate, One Hundred Seventh Congress, second session, March 14, 2002.
Published: (2002)

The complex web of prescription drug prices : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC.
Published: (2022)

Prescription drug therapies : reducing costs and improving outcomes /
by: Kass-Bartelmes, Barbara L.
Published: (2002)

Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002.
Published: (2003)

Medicare payments for currently covered prescription drugs : hearing before the Subcommittee on Health of the Committee on Ways and Means, House of Representatives, One Hundred Seventh Congress, second session, October 3, 2002.
Published: (2003)

Prescription drug pricing and negotiation : overview and economic perspectives for the Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, January 11, 2007.
Published: (2007)

Prescription drug pricing and negotiation : overview and economic perspectives for the Medicare prescription drug benefit : hearing before the Committee on Finance, United States Senate, One Hundred Tenth Congress, first session, January 11, 2007.
Published: (2007)

Prescription drug costs : what drives increases? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, 106th Congress, 2nd session ... July 18, 2000.
Published: (2000)

A Status report, accessibility and affordability of prescription drugs for older Americans : (includes a directory of pharmaceutical manufacturer indigent patient programs) : a staff report of the Special Committee on Aging, United States Senate.
Published: (1992)

Prescription drugs : out-of-pocket expenses and unmet need relative to family income, 2002 /
by: Crimmel, Beth Levin
Published: (2005)